SiriusPoint Ltd.
NYSE:SPNTInsurance - Reinsurance
-$0.26 today
- Market cap
- $2.98B
- Beta
- 0.62
- P/E (TTM)
- 5.3
- EPS (TTM)
- $4.28
Volume 1.13M
Average 0.73M
SPNT Cash & Equivalents
Cash on hand and highly liquid investments that can be converted to cash almost immediately.
SiriusPoint Ltd.NYSE: SPNT
Cash & Equivalents · Q2 FY2026 · quarter ended Jun 2026
Cash & equivalents broadly unchanged from a year ago
Cash & equivalents stood at $745.9M at the end of Q2 FY2026, up 1.8% from a year earlier and down 13.0% from the prior quarter. Over 3 fiscal years it compounded at +1.2% a year.
Context
- Cash & equivalents amounted to 5.9% of total assets at the end of Q2 FY2026, unchanged from a year earlier.
- Cash & equivalents increased in 2 of the last 3 fiscal years.
What to watch
Whether cash & equivalents keeps rising in the next quarterly balance sheet after a +1.8% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Cash & Equivalents history
USD · from the balance sheet
- Latest · FY2025
- 731.2M USD
- Year-over-year change
- +7.2%
- 4-year CAGR
- -7.5%
| Period | Period end | Cash & Equivalents | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 731.2M | +7.2% |
| FY2024 | 2024-12-31 | 682M | -29.6% |
| FY2023 | 2023-12-31 | 969.2M | +37.4% |
| FY2022 | 2022-12-31 | 705.3M | -29.5% |
| FY2021 | 2021-12-31 | 999.8M | — |
Cash & Equivalents vs competitors
How SPNT compares with its peers on the latest reported figures
- SPNT's Jun 2026 cash & equivalents of $745.9M is the 4th highest of the 11 companies compared; the peer median is $638.3M.
- Its year-over-year change of +1.8% is the 4th highest of 11, against a peer median of -15.2%.
- Cash & equivalents amounts to 5.9% of total assets for SPNT, versus a peer median of 3.6%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $29.18B | +640330.2% | -34.0% | 0.9% | |
MRXMarex Group plc Ordinary Shares | Jun 2026 | $3.85B | -44.3% | +91.4% | 9.1% |
| Sep 2026 | $3.62B | -13.4% | -48.6% | 13.2% | |
| Jun 2026 | $745.9M | +1.8% | +1.2% | 5.9% | |
| Jun 2026 | $717.34M | -27.2% | -0.4% | 7.0% | |
| Sep 2026 | $710.17M | -3.1% | -3.1% | 3.7% | |
| Dec 2025 | $566.44M | +20.5% | +73.9% | 8.5% | |
| Sep 2026 | $558.11M | -17.1% | -9.1% | 3.1% | |
| Sep 2026 | $215.47M | -66.3% | -2.1% | 1.3% | |
| Sep 2026 | $176.1M | -76.2% | -33.1% | 0.8% | |
| Dec 2025 | $47.41M | +12.3% | -5.9% | 3.4% | |
| Peer median (excluding SPNT) | $638.3M | -15.2% | -4.5% | 3.6% | |
Competitors are the stored peer set for SPNT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 999.8M | 705.3M | 969.2M | 682M | 731.2M |
| Short-term Investments | 1.08B | 3.62B | 2.72B | 3.12B | 2.62B |
| Net Receivables | 3.2B | 3.3B | 4.31B | 4.42B | 4.42B |
| Inventory | 0 | (6.34B) | (12.78B) | 0 | 0 |
| Other Current Assets | 3.04B | 3.62B | 5.31B | (8.69B) | 171.2M |
| Total Current Assets | 8.55B | 5.26B | 969.2M | 0 | 8.43B |
| Property, Plant & Equipment (Net) | 0 | 25.9M | 25.6M | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 390.7M | 163.8M | 152.7M | 468.3M | 505.3M |
| Long-term Investments | 1.37B | 5.15B | 6.08B | 2.58B | 2.98B |
| Tax Assets | 0 | 200.3M | 0 | 0 | 267.7M |
| Other Non-current Assets | 308.7M | (5.17B) | (435.2M) | 9.47B | 387.3M |
| Total Non-current Assets | 2.07B | 364.1M | 5.82B | 12.52B | 4.14B |
| Total Assets | 10.62B | 11.04B | 12.87B | 12.52B | 12.57B |
| Account Payables | 924.6M | 1.08B | 2.02B | 1.8B | 1.45B |
| Short-term Debt | 0 | 0 | 0 | 0 | 0 |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | (18M) | 0 | 0 | 1.86B |
| Other Current Liabilities | (924.6M) | 3.83B | (2.01B) | 4.15B | 2.01B |
| Total Current Liabilities | 0 | 4.89B | 6.2M | 5.94B | 5.32B |
| Long-term Debt | 816.7M | 778M | 786.2M | 639.1M | 688.6M |
| Deferred Tax Liabilities | 95.4M | 59.8M | 68.7M | 76.2M | 73M |
| Deferred Revenue (Non-current) | 0 | 0 | 27.9M | 8.5M | 0 |
| Other Non-current Liabilities | 5.71B | 3.23B | 9.45B | 3.92B | 4.02B |
| Total Non-current Liabilities | 6.66B | 4.06B | 10.33B | 4.64B | 4.78B |
| Total Liabilities | 8.12B | 8.95B | 10.34B | 10.59B | 10.1B |
| Common Stock | 16.2M | 16.2M | 16.8M | 11.6M | 11.7M |
| Retained Earnings | 665M | 262.2M | 601M | 784.9M | 1.23B |
| Accumulated OCI | (200K) | (45M) | 3.1M | (4.1M) | 61.9M |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | (400K) | 7.9M | 16.7M | 1.4M | 1.1M |
| Total Equity | 2.5B | 2.08B | 2.53B | 1.94B | 2.47B |
| Total Debt | 816.7M | 778M | 786.2M | 639.1M | 688.6M |
| Net Debt | (183.1M) | 72.7M | (183M) | (42.9M) | (42.6M) |
SiriusPoint Ltd.
NYSE:SPNT
Intrinsic Alpha fair value
Locked
Current Price
$25.92
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.